Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.

Front Immunol · 2022 · PMC9557176 · PMID 36248874

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Comparing the number of publications on targeted immunotherapy for NMOSD, MS and MG, they all show an increasing trend, but each disease has its own unique increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.